Evidence map›Paper›PMID 31588683›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2019

Isolation and Profiling of Circulating Tumor-Associated Exosomes Using Extracellular Vesicular Lipid-Protein Binding Affinity Based Microfluidic Device.

Yoon-Tae Kang, Emma Purcell, Colin Palacios-Rolston, Ting-Wen Lo, Nithya Ramnath, Shruti Jolly, Sunitha Nagrath

Open access · bronzeAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 160 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Isolation methods of exosomes derived from dental stem cells.International journal of oral science · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yoon-Tae KangDepartment of Chemical Engineering and Biointerface Institute, University of Michigan, 2800 Plymouth Road, NCRC B10-A184, Ann Arbor, MI, 48109, USA.ORCID 0000-0003-1596-7815
Emma PurcellDepartment of Chemical Engineering and Biointerface Institute, University of Michigan, 2800 Plymouth Road, NCRC B10-A184, Ann Arbor, MI, 48109, USA.ORCID 0000-0003-4653-4756
Colin Palacios-RolstonDepartment of Chemical Engineering and Biointerface Institute, University of Michigan, 2800 Plymouth Road, NCRC B10-A184, Ann Arbor, MI, 48109, USA.
Ting-Wen LoDepartment of Chemical Engineering and Biointerface Institute, University of Michigan, 2800 Plymouth Road, NCRC B10-A184, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-2127-2000
Nithya RamnathDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Shruti JollyDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, 1500 E Medical Center Dr., Ann Arbor, MI, 48109, USA.
Sunitha NagrathDepartment of Chemical Engineering and Biointerface Institute, University of Michigan, 2800 Plymouth Road, NCRC B10-A184, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-1497-7977
University of Michigan · US

Funding

Microfluidics in Biomedical Sciences Training ProgramT32EB005582 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FAN, XUDONG · 2005 to 2020
$3.9M
Label free microfluidic isolation, characterization and ex vivo expansion of CTCsR01CA208335 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NAGRATH, SUNITHA · 2017 to 2021
$2.8M
High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug TestingR33CA202867 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NAGRATH, SUNITHA, RAMNATH, NITHYA · 2016 to 2018
$1.0M
NCI NIH HHS R01 CA208335NCI NIH HHS R33 CA202867NIBIB NIH HHS T32 EB005582
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are emerging as a potential diagnostic test for cancer. Owing to the recent advances in microfluidics, on-chip EV isolation is showing promise with respect to improved recovery rates, smaller necessary sample volumes, and shorter processing times than ultracentrifugation. Immunoaffinity-based microfluidic EV isolation using anti-CD63 is widely used; however, anti-CD63 is not specific to cancer-EVs, and some cancers secrete EVs with low expression of CD63. Alternatively, phosphatidylserine (PS), usually expressed in the inner leaflet of the lipid bilayer of the cells, is shown to be expressed on the outer surface of cancer-associated EVs. A new exosome isolation microfluidic device (

Indexed as

Lab-On-A-Chip DevicesA549 CellsExosomesHumansLipidsNeoplasmsProtein BindingReproducibility of ResultsTetraspaninsLipidsTetraspaninscancer-associated exosomesexosome isolationextracellular vesicleslung cancermelanomamicrofluidics

Identifiers

PMID31588683
PMCPMC6951813
OpenAlexW2980151372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.